Alpha-Ketoglutaric Acid

Alpha-Ketoglutaric Acid

SCHEMBL174485

CC1(Cl)CNCCc2ccccc21.O=C(O)CCC(=O)C(=O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.37
HTR2C P28335 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
MAPK1 P28482 1/20 0.34
SLC13A3 Q8WWT9 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
OR51E2 Q9H255 1/20 0.34
DRD2 P14416 2/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
NOTUM Q6P988 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
DRD1 P21728 1/20 0.33
APEX1 P27695 1/20 0.32
HRH1 P35367 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL175159 0.94 HTR2A (0.41) HTR2AHTR2CL3MBTL1DRD2SLC6A2
Adipic Acid SCHEMBL173981 0.89 L3MBTL1 (0.41) HTR2AHTR2CL3MBTL1MAPK1DRD2
Malonic Acid SCHEMBL174326 0.86 HTR2A (0.41) HTR2AHTR2CDRD2SLC6A2SLC6A4
Glycolic Acid SCHEMBL174591 0.86 HTR2A (0.41) HTR2AHTR2CDRD2SLC6A2SLC6A4
SCHEMBL173319 0.81 HTR2A (0.51) HTR2AHTR2CMAPK1DRD2SLC6A2
Alpha-Ketoglutaric Acid SCHEMBL16464850 0.80 HTR2C (0.53) HTR2CL3MBTL1MAPK1SLC13A3EGLN1
Hydrochloric Acid SCHEMBL5317898 0.80 HTR2A (0.50) HTR2AHTR2CDRD2SLC6A2SLC6A4
Citric Acid SCHEMBL173747 0.80 SLC13A5 (0.39) HTR2AHTR2CL3MBTL1MAPK1ALDH1A1
Phosphoric Acid SCHEMBL174685 0.79 HTR2A (0.44) HTR2AHTR2CL3MBTL1DRD2SLC6A2
SCHEMBL174465 0.78 HTR2C (0.43) HTR2AHTR2CDRD2SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611427-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT& xA; Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030927-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed